Your browser doesn't support javascript.
loading
Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma.
Sommer, Cesar; Boldajipour, Bijan; Kuo, Tracy C; Bentley, Trevor; Sutton, Janette; Chen, Amy; Geng, Tao; Dong, Holly; Galetto, Roman; Valton, Julien; Pertel, Thomas; Juillerat, Alexandre; Gariboldi, Annabelle; Pascua, Edward; Brown, Colleen; Chin, Sherman M; Sai, Tao; Ni, Yajin; Duchateau, Philippe; Smith, Julianne; Rajpal, Arvind; Van Blarcom, Thomas; Chaparro-Riggers, Javier; Sasu, Barbra J.
Afiliación
  • Sommer C; Allogene Therapeutics, Inc., 210 E. Grand Avenue, South San Francisco, CA 94080, USA. Electronic address: cesar.sommer@allogene.com.
  • Boldajipour B; Pfizer Cancer Immunology Discovery, Pfizer Worldwide Research and Development, 230 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Kuo TC; Pfizer Cancer Immunology Discovery, Pfizer Worldwide Research and Development, 230 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Bentley T; Allogene Therapeutics, Inc., 210 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Sutton J; Allogene Therapeutics, Inc., 210 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Chen A; Pfizer Cancer Immunology Discovery, Pfizer Worldwide Research and Development, 230 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Geng T; Pfizer Cancer Immunology Discovery, Pfizer Worldwide Research and Development, 230 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Dong H; Pfizer Cancer Immunology Discovery, Pfizer Worldwide Research and Development, 230 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Galetto R; Cellectis SA, 8 rue de la Croix Jarry, 75013 Paris, France.
  • Valton J; Cellectis, Inc., 430 East 29th Street, New York, NY 10016, USA.
  • Pertel T; Allogene Therapeutics, Inc., 210 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Juillerat A; Cellectis, Inc., 430 East 29th Street, New York, NY 10016, USA.
  • Gariboldi A; Cellectis SA, 8 rue de la Croix Jarry, 75013 Paris, France.
  • Pascua E; Pfizer Cancer Immunology Discovery, Pfizer Worldwide Research and Development, 230 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Brown C; Pfizer Cancer Immunology Discovery, Pfizer Worldwide Research and Development, 230 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Chin SM; Pfizer Cancer Immunology Discovery, Pfizer Worldwide Research and Development, 230 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Sai T; Pfizer Cancer Immunology Discovery, Pfizer Worldwide Research and Development, 230 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Ni Y; Allogene Therapeutics, Inc., 210 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Duchateau P; Cellectis SA, 8 rue de la Croix Jarry, 75013 Paris, France.
  • Smith J; Cellectis, Inc., 430 East 29th Street, New York, NY 10016, USA.
  • Rajpal A; Pfizer Cancer Immunology Discovery, Pfizer Worldwide Research and Development, 230 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Van Blarcom T; Allogene Therapeutics, Inc., 210 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Chaparro-Riggers J; Pfizer Cancer Immunology Discovery, Pfizer Worldwide Research and Development, 230 E. Grand Avenue, South San Francisco, CA 94080, USA.
  • Sasu BJ; Allogene Therapeutics, Inc., 210 E. Grand Avenue, South San Francisco, CA 94080, USA. Electronic address: barbra.sasu@allogene.com.
Mol Ther ; 27(6): 1126-1138, 2019 06 05.
Article en En | MEDLINE | ID: mdl-31005597

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Inmunoterapia Adoptiva / Trasplante de Células / Antígeno de Maduración de Linfocitos B / Receptores Quiméricos de Antígenos / Mieloma Múltiple Tipo de estudio: Evaluation_studies Límite: Animals / Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Inmunoterapia Adoptiva / Trasplante de Células / Antígeno de Maduración de Linfocitos B / Receptores Quiméricos de Antígenos / Mieloma Múltiple Tipo de estudio: Evaluation_studies Límite: Animals / Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos